国产热热热精品,亚洲视频久久】日韩,三级婷婷在线久久,99人妻精品视频,精品九热人人肉肉在线,AV东京热一区二区,91po在线视频观看,久久激情宗合,青青草黄色手机视频

Global EditionASIA 中文雙語Fran?ais
World
Home / World / Asia-Pacific

Test kit issue of ICMR can be resolved with good will as priority attached to quality of medical exports

chinadaily.com.cn | Updated: 2020-04-28 13:40
Share
Share - WeChat
The novel coronavirus testing kit produced by Guangzhou Wondfo Biotech Co Ltd, [Photo provided to chinadaily.com.cn]

China not only attaches importance to the quality of medical exports, but also takes concrete actions to sincerely help and support India in the fight against COVID-19, said a spokesperson from the Chinese Embassy in India.

Regarding the announcement of the Indian Council of Medical Research to stop using rapid antibody test kits from two Chinese companies, Counselor Ji Rong said, "We hope the Indian side could respect China's goodwill and sincerity, strengthen communication timely with relevant Chinese companies based on facts, and resolve it reasonably and properly."

Both companies are concerned. In their statement, they said the kits have been exported to and well recognized in many countries in Europe, Asia and Latin America. The same kits have been validated and approved by ICMR through National Institute of Virology (NIV), Pune and considered as satisfactory products, as well meeting the quality standards of China and exported countries.

"We have also learned that there are strict requirements for the storage, transportation and use of COVID-19 antibody rapid test kits," Ji said. "Any operation which is not carried out by professionals in accordance with the product specifications will lead to the testing accuracy variations."

ICMR also made it clear that rapid antibody test kits should only be used for surveillance purposes instead of replacing RT-PCR test to diagnose and confirm the cases, and Indian states are advised to strictly abide by the methods and purpose of the usage according to ICMR's clear instructions.

"It is unfair and irresponsible for certain individuals to label Chinese products as "faulty" and look at issues with pre-emptive prejudice," Ji added.

China and India have maintained close communication and cooperation on epidemic prevention and control. Following India's pandemic situation, China has shared its experiences in prevention, control and treatment, and donated medical materials to India.

"We will continue to support India's efforts in fighting COVID-19, strengthen medical and health cooperation, and jointly work with India to overcome the difficulties at an early date, so as to safeguard the safety and health of our peoples as well as global and regional public health security," Ji said.

Most Viewed in 24 Hours
Top
BACK TO THE TOP
English
Copyright 1994 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
富蕴县| 大连市| 伊通| 五峰| 元阳县| 连平县| 安福县| 沛县| 化隆| 纳雍县| 宁都县| 鄂托克前旗| 安徽省| 鄂温| 雷州市| 浦江县| 马公市| 荥经县| 沭阳县| 久治县| 萍乡市| 西吉县| 卢氏县| 阿勒泰市| 怀化市| 衡水市| 东安县| 乌恰县| 东台市| 遵义县| 东港市| 三穗县| 兴隆县| 梁山县| 望谟县| 车致| 宜丰县| 平果县| 凤翔县| 辛集市| 霞浦县|